Current Infectious Disease Reports

, Volume 8, Issue 4, pp 293–300


  • Vincent C. Marconi
  • Hector H. Garcia
  • Joel T. Katz

DOI: 10.1007/s11908-006-0074-9

Cite this article as:
Marconi, V.C., Garcia, H.H. & Katz, J.T. Curr Infect Dis Rep (2006) 8: 293. doi:10.1007/s11908-006-0074-9


Since international travel has become widespread, clinicians increasingly have been confronted with the diagnosis of symptomatic and incidental neurocysticercosis. The difficulty with managing this disease lies in its varied clinical presentations. The treatment of neurocysticercosis depends upon anatomic locations, stages of cysts, and overall cyst burden. Despite recent clinical and laboratory advances, experts are divided on many key management questions. This article reviews the pathophysiology and experimental data underlying treatment recommendations for this emerging and complex condition.

Copyright information

© Current Science Inc 2006

Authors and Affiliations

  • Vincent C. Marconi
  • Hector H. Garcia
  • Joel T. Katz
    • 1
  1. 1.Medicine Education OfficeBrigham and Women’s HospitalBostonUSA

Personalised recommendations